Rhiannon French

Maindy Road
Cardiff, WLS CF244HQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Pharmacological Inhibition of cFLIP Targets Breast Cancer Stem Cells.

Pharmacological Inhibition of cFLIP Targets Breast Cancer Stem Cells.

Journal: Journal of cancer treatment & diagnosis
Published: October 13, 2025

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity.

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity.

Journal: British journal of cancer
Published: June 04, 2025

Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.

Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.

Journal: Seminars in cancer biology
Published: July 13, 2022

Epigenetic regulation of cancer stem cell formation and maintenance.

Epigenetic regulation of cancer stem cell formation and maintenance.

Journal: International journal of cancer
Published: July 17, 2020

The Discovery of a Novel Antimetastatic Bcl3 Inhibitor.

The Discovery of a Novel Antimetastatic Bcl3 Inhibitor.

Journal: Molecular cancer therapeutics
Published: April 09, 2020

Targeting TGFβ Signalling in Cancer: Toward Context-Specific Strategies.

Targeting TGFβ Signalling in Cancer: Toward Context-Specific Strategies.

Journal: Trends in cancer
Published: March 23, 2020

Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection.

Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection.

Journal: Cancer immunology research
Published: January 24, 2020

Heterogeneity of Mammary Stem Cells.

Heterogeneity of Mammary Stem Cells.

Journal: Advances in experimental medicine and biology
Published: September 06, 2019

Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.

Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.

Journal: Breast cancer research and treatment
Published: November 14, 2016

Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.

Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.

Journal: Molecular cancer
Published: June 05, 2015

Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Journal: Breast cancer research : BCR
Published: May 28, 2014

Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.

Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.

Journal: Cancer research
Published: November 15, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026